DOWNLOAD PROGRAM

Preliminary

Thursday 8th October 2026 (Day 1)
08.00-13.00 Registration Open
  • Possible Industry Sponsored session in the morning (TBC)
  • Early Career Researchers Networking Event (TBC)
 13.00 Opening Ceremony and Welcome

Denice Feig (IADPSG), Lene Ringholm (DPSG) & Rosa Corcoy (Local Organising Committee)

13.10-14.50 Session 1

Technology and Type 1 diabetes: Hybrid Closed Loop Trials and Real-World Data
Chairs: Denice Feig & Rosa Corcoy

  • 13:10-13.30 Helen Murphy, UK: AiDAPT
  • 13:30-13.50 Katrien Benhalima, Belgium: CRISTAL
  • 13:50-14.10 Lois Donovan, Canada: CIRCUIT
  • 14:10-14.30 Carmen Quirós, Spain: Real-World HCL Data
  • 14:30-14.50 Panel Discussion
14.50-15.20 Coffee Break
15.20-17.20 Session 2

Gestational Diabetes: Stratifying Care to Improve Outcomes

  • 15:20-15.40 Ponnusamy Saravanan, UK: Use of Early HbA1c to reduce need for OGTT
  • 15:40-16.00 David Simmons, Australia: Use of Early Higher OGTT cut-offs to Target Care
  • 16:00-16.20 Rajeev Chawla, India: Early Diagnosis of GDM at <10 weeks gestation to Improve Care in India
  • 16:20-16.50 Oral Abstract Presentations (30 min)
16.50 – 17.50 Session 3

Debate:
Should Maternal Weight Gain be limited to <5 kg in Obese Women during Pregnancy?
Claire Meek, UK (Pro) vs Rosa Corcoy, Spain  (Con)

18.00 h Welcome drinks reception

Dinner – free to arrange

Friday 9th October 2026 (Day 2)
09.00-10.50 Session 4

Continuous Glucose Monitoring: Utilizing the Potential of CGM in Diabetes Pregnancy
Chairs: Lene Ringholm

  • 09:00-09.20 Celeste Durnwald, USA: The Glucose Levels Across Maternity (GLAM)
  • 09:20-09.40 Eleanor Scott, UK: Maternal Glucose in Pregnancy (MAGIC)
  • 09:40-10.00 Patrick Catalano, USA: Glycemic Observations and Metabolic Outcomes in Mothers (GO MOMS)
  • 10.00-10.20 Lene Ringholm, Denmark: What we have learned from the CopenFAST trial
  • 10.20-10.50 Oral Abstract Présentations (30 min)
10.50-11.30 Coffee Break
11.30-12.40 Session 5

Lessons from Basic Science: Potential to Improve Clinical Care

  • 11:30-11.50 Karen Forbes, UK: Role of MicroRNA’s in LGA and placental function
  • 11:50- 12.10 Arianne Sweeting, Australia: Potential precision markers for GDM
  • 12:10-12.40 Oral Abstract présentations (30 min)
12.40-13.40 Lunch
13.40-14.40 Poster Viewing
14.40-15:50 Session 6

Managing Hypertensive Disorders in Pregnancy in Women with Diabetes

  • 14:40-15.00 Jenny Myers, UK: Overview of Preeclampsia and HDP
  • 15:00-15.20 Lori Harper, USA: How low should BP go in Diabetes in Pregnancy?
  • 15:20-15.50 Oral Abstract présentations (30 min)
15.50-16.20 Coffee Break
16.20-17.30 Session 7

Award session

  • DPSG Award Lectures
    • 16.20-16.50   Joseph Hoet Award
    • 16.50-17.20   Jorgen Pedersen Award
  • 17:20-17:30 IADPSG-DPSG Young Investigator Travel awards delivery
17.30-18.30  DPSG Annual Business Meeting (members only)

Chair: Lene Ringholm

Conference Dinner (External venue, additional cost)

Saturday 10th October 2026 (Day 3)
09.00-10.30 Session 8

GImpact of Diabetes on the Developing Fetus: Lessons from Basic Science

  • 09:00-09.20 Shalini Jaggi, India: Fetal brain development in GDM
  • 09:20-09.40 Jami Josefson, USA: DNA methylation and fetal programming of neonatal adiposity
  • 09:40-10.00 Alicia Jawerbaum, Argentina: Effect of maternal diets enriched in unsaturated fatty acids
  • 10:00-10.30 Oral Abstract Presentations (30 min)
10:30-11:00 Break
11.00-12.30 Session 9

How do I…..?

  • 11:00-11.20 Manuela Fernandez-Lopez, Spain: Use fetal US to guide therapeutic decisions in managing GDM?
  • 11:20-11.40 Jennifer Yamamoto, Canada: …Diagnose Type 2 Postpartum (PREDISPOSE)
  • 11:40-12.00 Roland Devlieger, Belgium: …Diagnose GDM following bariatric surgery and treat in pregnancy?
  • 12:00-12.30 Elisabeth Mathiesen, Denmark: …Manage diabetes retinopathy during pregnancy?
12.30-13.30 Lunch
13.30-14:30 Poster Viewing
14.30-16:00 Session 10

Long-Term Outcome of Offspring of Diabetes in Pregnancy
Chairs: Lene Ringholm

  • 14:30 -14.50 Moshe Hod, Israel: FIGO update
  • 14:50-15.10 Denice Feig, Canada: MiTy (Metformin in women with T2D in pregnancy) Tykes
  • 15:10-15.30 Ronald Ma, Hong Kong/China: Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) Follow up
  • 15:30-16.00 Oral Abstract Presentations (30 min)
16.00 – 16.30 Coffee Break
16.30 -17.40 Session 11

GLP1-Receptor Agonists: Before, During and After Pregnancy

  • 16:30-16.50 Camille Powe, USA: Pre-pregnancy and pregnancy use of GLP1 Agonists and Pregnancy Outcomes
  • 16:50-17.10 Signe Foghsgaard, Denmark: GLP-1 following GDM
  • 17:10-17.40 Oral Abstract Presentations (30 min)
17:40 Closing ceremony

(Denice Feig and Lene Ringholm)